The Hirbe Lab is a passionate group of clinicians and scientists working collaboratively with many labs. We use our diverse talents to address a broad range of questions regarding sarcoma biology, especially as it relates to understanding MPNSTs and clinically relevant therapies. Read below to find out more about each person!
Xiaochun Zhang

LAB MANAGER
Beginning in 1997, I was doing research on the role of p53, and p16 in non-small cell lung cancer (NSCLC) at Nanchang University in China. When I arrived at Washington University in 2000, I started working projects on neurodegeneration and cell migration. I then moved on to the Siteman Cancer Tissue Procurement core facility and collaborated with more than 100 cancer research groups. While there, we teamed up with the genomic Institute of Washington University and I started collaborating with Dr. Angela Hirbe. Together I helped her study MPNSTs to better understand the pathogenesis and the biomarkers of the MPNSTs diagnosis and therapy. I’ve been with Dr. Hirbe’s team since September 2016 as a Staff Scientist. My research interests are in the identified BetaIII-spectrin protein as a frequently mutated gene in human MPNSTs, whose function is critical for mouse MPNST growth in vivo and as a potential diagnostic and prognostic marker for MPNST development and progression.
Carina Dehner

ANATOMIC PATHOLOGY RESIDENT AND FUTURE DERMPATH AND BONE AND SOFT TISSUE FELLOW
My research interest is understanding the molecular-genetic mechanisms of high-grade transformation in mesenchymal neoplasms. In our recent paper, we have shown that Chr8q gain plays a role in high-grade transformation into Malignant Peripheral Nerve Sheath Tumor. We have also shown that Chr8q is associated with worse overall survival in other sarcomas. First, I am hoping to study what types of sarcoma are those showing Chr8q gain using Fluorescence in situ hybridization (FISH) and TCGA analysis. Then I am hoping to define potential driver genes of high-grade transformation in these sarcomas using PDX, cell culture models, FISH, and trisomy 8 fibroblasts. The overall goal is to identify new, targetable drivers of high-grade transformation in order to establish efficacious and more specific therapeutic options.
Yang Lyu

Staff Scientist
I got my PhD degree in nephrology in 2010, China. In 2018, I moved to Washington University in Saint Louis, starting my single-cell research and bioinformatics work here.
I specialize in NGS data analysis, including tumor microenvironment analysis. I am currently investigating how to apply bioinformatics in tumor precise therapies.
Dr. Dana Borcherding

SENIOR SCIENTIST
My research project investigates the role of TYK2 in the pathogenesis of malignant peripheral nerve sheath tumors (MPNST), aggressive sarcomas with poor prognosis. Composed of neoplastic Schwann cells, these cancers recur in ~50% of individuals, and most people die within five years of diagnosis, despite surgical resection, radiation, and chemotherapy. Thus, there is an urgent need to identify novel therapeutic targets. Prior work from our laboratory identified TYK2 genetic mutations in a subset of MPNSTs and showed that knockdown of the TYK2 gene in MPNST cell lines decreases proliferation and increases apoptosis in vitro. Furthermore, genetic knockdown of TYK2 in murine MPNST cells resulted in decreased tumor burden of subcutaneous and metastatic tumor models. The goals of my project are to determine the molecular mechanisms of TYK2 action in MPNST cells and whether TYK2 is a prognostic biomarker for MPNST in patient tumor samples. My project will also evaluate pharmacologic inhibition of TYK2 in MPNST in mice. Additionally, I am involved in the development of clinical and genomic databases for patients with MPNST and other sarcomas. The overall aim of my studies is to develop more efficacious therapeutic options for patients with MPNST to improve patient outcomes and survival.
Kuangying Yang

GRADUATE STUDENT
I am a PhD student in Human & Statistical Genetics at Washington University. My research interests are focused on the genetic profiles and therapeutic targets of MPNSTs. I am aiming to figure out the MPNST pathogenesis with bulk and single cell RNA-Seq analyses so as to explore the novel treatments for patients with NF1-MPNST.
Kevin He

UNDERGRADUATE RESEARCH STUDENT
My project involves understanding whether or not TYK2 expression can be used as a prognostic marker for MPNST.
Simge Acar

VISITING RESEARCHER
I graduated from Koç University School of Medicine in Istanbul, Turkey, and joined Hirbe Lab. My research project investigates altered transcriptome and proteome that occurs in cells with chromosome 8q gain. Chr8 gain was identified as a near-universal event in MPNST and is associated with poor overall survival. With a deeper understanding of the molecular pathogenesis of MPNST, and how Chr8 gain alters the biology of MPNST, we hope to uncover new opportunities for the development of novel therapeutic strategies that may improve clinical outcomes.
Neha Amin

UNDERGRADUATE RESEARCH STUDENT
My project involves evaluating targeting the TYK2 kinase in treating Plexiform NF and MPNST.
Divya Srihari

UNDERGRADUATE RESEARCH STUDENT
My research interests are focused on developing tools to aid in early diagnosis of NF1-MPNSTs. I am particularly interested in utilizing liquid biopsies to detect circulating tumor DNA to aid in early detection of malignant transformation in patients with NF1.
Terrie Stald
ADMINISTRATIVE ASSISTANT
Lab Alumni
We have been very lucky to have worked alongside creative and interesting scientists in the Hirbe Lab. Sad for us, they have gone on to continue their aspirations and careers all over the country and the globe.
Layla Daud

STARs High School Summer Student – 2022
Dr. Himanshi Bhatia

POST-DOCTORAL FELLOW
Dr. Bhatia is now working for Sanofi.
Vanessa Eulo

HEMATOLOGY/ONCOLOGY FELLOW
Dr. Vanessa Eulo, Assistant Professor, Sarcoma Section Head, University of Alabama, Birmingham
Hua Xu

VISITING SCHOLAR
Attending physician from The First Affiliated Hospital of Nanchang University, Jiangxi Province, China
Xiaodan Wan

VISITING SCHOLAR
Attending physician from The First Affiliated Hospital of Nanchang University, Jiangxi Province, China
Zhaohe Zhou

GRADUATE STUDENT RESEARCH ASSISTANT
Instructor, Chengdu University, China
Chang In Moon

GRADUATE STUDENT RESEARCH ASSISTANT
PhD student, Baylor College of Medicine
Yuxi Wang

RESEARCH ASSISTANT
Masters student, University of Cambridge
Daniel Schefer

UNDERGRADUATE RESEARCH STUDENT
Scientist, Inspira
Hillary Dietz

CLINICAL RESIDENT
Hematology Oncology Fellow, Duke University
Tyler Ball

RESEARCH TECHNICIAN
Olivia Cobb

GRADUATE STUDENT RESEARCH ASSISTANT
Abigail Godec

RESEARCH TECHNICIAN
MD/PhD Candidate at Michigan State

Wenjing Qin
GRADUATE STUDENT
Associate Researcher, Nanchung University
Xue-Liang Zhou

POST-DOCTORAL FELLOW
Associate Professor, Nanchung University
Neha Amin and Natalie Loveridge
STARs High School Summer Students – 2019

Emily Ristevski and Avi Saini
STARs High School Summer Students – 2018
